ClinicalTrials.govpublic full text
Predicting Olaparib Sensitivity in Patients With Unresectable Locally Advanced/Metastatic HER2-negative Breast Cancer.
her2-negative breast cancer, metastatic breast cancer, triple negative breast cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 836341
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.